Gastric Cancer Management and Outcomes

SEP 9, 2026 · JOURNAL ARTICLE

Gastric Mucosa Cancer Risk: The Operative Link on Gastritis Assessment Staging System

The Korean Journal of Helicobacter and Upper Gastrointestinal Research

A narrative review synthesizing evidence on gastric atrophy staging and risk stratification to inform clinical surveillance strategy and serological monitoring in individual patients.

SEP 8, 2026 · JOURNAL ARTICLE

Efficacy of a phlegm-resolving traditional Chinese medicine regimen in advanced gastric cancer: A retrospective observational study

Eurasian Journal of Medicine and Oncology

Retrospective observational study without randomization or blinding, comparing historical cohorts with overlapping confidence intervals on the primary endpoint, raising hypothesis rather than establishing efficacy.

SEP 7, 2026 · JOURNAL ARTICLE

Clinical translation of CLDN18.2 and FGFR2b targeting in gastric cancer through assay thresholds and combination strategies

Discover Oncology

A narrative review synthesizing evidence across randomized trials and translational studies to distinguish established clinical practice from exploratory strategies in gastric cancer biomarker-directed therapy.

SEP 5, 2026 · JOURNAL ARTICLE

Comparative efficacy and safety of neoadjuvant and perioperative systemic therapies for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma: a network meta analysis of randomized controlled trials

BMC Gastroenterology

Network meta-analysis of 36 RCTs with 8925 patients comparing defined treatment classes for resectable locally advanced gastric cancer, with consistent superiority of chemotherapy plus immunotherapy across survival and pathological endpoints, but limited by indirect comparisons and heterogeneous trial populations.

SEP 5, 2026 · JOURNAL ARTICLE

Assessing quality in minimally invasive D2 lymphadenectomy: from technical difficulty to AI-enabled audit

World Journal of Surgical Oncology

A narrative framework review synthesizing evidence on technical difficulty, surgical quality assessment, and AI-enabled audit for minimally invasive D2 lymphadenectomy, proposing guidance for quality measurement and process review.

SEP 4, 2026 · JOURNAL ARTICLE

Associations of baseline [18F]FDG PET/CT metabolic parameters with the efficacy of neoadjuvant immunotherapy plus concurrent chemoradiotherapy in patients with locally advanced gastric adenocarcinoma: a post hoc analysis of the Neo-PLANET phase II trial

BMC Medical Imaging

Post hoc analysis of a phase II trial with small sample (n=29) and surrogate/exploratory endpoints; findings are hypothesis-generating and require validation in larger populations.

SEP 4, 2026 · JOURNAL ARTICLE

Heterogeneity-oriented multidisciplinary and super-minimally invasive precision treatment framework for locally advanced gastric cancer

World Journal of Translational Medicine

This is a conceptual framework paper proposing a treatment approach for locally advanced gastric cancer, explicitly lacking primary clinical data and validation, presented as a hypothesis-driven concept requiring future prospective testing.

AUG 17, 2026 · REVIEW

Efficacy hierarchy and absolute survival benefit of first-line immunotherapy in advanced gastric cancer: a meta-analysis and pooled survival analysis

Frontiers in Immunology

High-quality meta-analysis of 8 phase III RCTs with 7,127 patients showing consistent, statistically significant OS and PFS benefit for ICI-chemotherapy over chemotherapy alone in advanced gastric cancer, with clinically meaningful absolute survival gains and manageable toxicity.